Literature DB >> 10720990

Neonatal urticaria due to prostaglandin E1.

E L Carter1, M C Garzon.   

Abstract

Prostaglandin E1 is commonly used in the management of cyanotic congenital heart disease. While cutaneous flushing and peripheral edema are well recognized side effects of prostaglandin E1 therapy, other cutaneous effects have not been described in the dermatologic literature. We report a neonate with transposition of the great vessels who developed urticaria during treatment with prostaglandin E1.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10720990     DOI： 10.1046/j.1525-1470.2000.01712.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  4 in total

1.  Saturation with oxygen for ductal dependent congenital heart diseases before and after the prostaglandin therapy.

Authors:  Senka Dinarević; Hajrija Maksić; Majda Haznadar
Journal:  Bosn J Basic Med Sci       Date:  2005-02       Impact factor: 3.363

2.  Urticaria due to Urtica dioica in a neonate.

Authors:  Sinan Uslu; Ali Bulbul; Betul Diler; Evrim Kiray Bas; Asiye Nuhoglu
Journal:  Eur J Pediatr       Date:  2010-10-16       Impact factor: 3.183

3.  Cutaneous eruption in neonate with congenital heart defect.

Authors:  Justin Raman; Amy Wells; Michael Chung; Sami K Saikaly; Nicole Bender
Journal:  JAAD Case Rep       Date:  2022-08-23

4.  An unusual migratory polycyclic eruption after administration of prostaglandin E in a neonate.

Authors:  Grace J Young; Nicole Harter; Minnelly Luu
Journal:  JAAD Case Rep       Date:  2016-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.